Focus:
Apple has joined forces with Eli Lilly and Evidation Health on a new feasibility study to detect evidence of brain decline with data from personal digital devices.
Synaptive Medical has launched surgical planning tool Modus Plan, featuring BrightMatter AutoSeg, for neurosurgeons in the US.
NeuroEM Therapeutics has reported positive data from the trial of a transcranial electromagnetic treatment (TEMT) with the company’s investigational MemorEM head device to treat Alzheimer’s disease (AD).
Patients with paralysis-related speech loss could benefit from a new technology developed by University of California San Francisco (UCSF) researchers that turns brain signals for speech into written sentences.
Cluster headache patients experience excruciating and debilitating attacks of pain that differs from tension headache in the location, severity of pain and frequency of attacks. GammaCore, is a portable, non-drug,...
Medical device company Flow has announced that it has raised $1.5m towards its transcranial direct current stimulation (tDCS) device for the treatment of depression.
Brain-computer interface (BCI) research is a rapidly evolving field with growing clinical interest for systems that allow patients suffering from neurological disorders to independently interact with their environment.
Researchers from the National University of Singapore (NUS) have invented a new blood test known as Amplified Plasmonic Exosome (Apex), capable of detecting a molecule that indicates early-stage Alzheimer's disease...
C4X Discovery (C4XD) has partnered with UK-based biopharmaceutical company PhoreMost to accelerate the Parkinson’s Disease drug discovery pipeline.
Changes to the serotonin system of the brain could act as a crucial early warning signal for Parkinson’s disease and may lead to the development of new screening tools for...
